The typical serving for a 500 kg (1,100 lb) horse is 10 g per day, providing 10 g of Acetyl-L-Carnitine Hydrochloride
Current classification frameworks categorize DDS into three principal classes: lipid-based, polymer-based, and other systems
Clinical trials in type 2 diabetic patients showed no significant worsening of glycemic control over 12 weeks of treatment
A pilot clinical trial in 12 healthy adults (ages 50-80) found that oral liposomal glutathione (500-1,000 mg/day) produced maximum increases of 40% in whole blood, 28% in plasma, and 100% in peripheral blood mononuclear cells (PBMCs) within two weeks, alongside a 35% reduction in plasma 8-isoprostane, a validated oxidative stress marker

Heres the simplified breakdown of why this combo is getting attention: Retatrutide (triple-agonist GLP-1/GIP/Glucagon) Often discussed for its potential to support: Reduced appetite Improved glucose control Significant fat-loss support in clinical trials Higher metabolic expenditure due to glucagon activity Tesamorelin (GHRH analog) People highlight it for: Supporting growth-hormone release Potential reduction of visceral fat Possible improvements in muscle preservation and metabolic health Ipamorelin (GHRP) Often noted for: Gentle GH stimulation Recovery support Better sleep quality reports Minimal cortisol/prolactin spikes vs older GHRPs Why the stack gets attention: Fitness and longevity circles often say this trio may offer a dual-path approach metabolic regulation (retatrutide) + hormone-mediated body recomposition (tesamorelin/ipamorelin)